LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 504

Search options

  1. Article ; Online: Heart failure with preserved ejection fraction in patients with moderate/severe aortic stenosis: what harms our patients most?

    Bergmann, Martin W

    European heart journal. Cardiovascular Imaging

    2023  Volume 25, Issue 3, Page(s) 313–314

    MeSH term(s) Humans ; Stroke Volume ; Hemodynamics ; Aortic Valve Stenosis/diagnostic imaging ; Aortic Valve Stenosis/surgery ; Aortic Valve Stenosis/physiopathology ; Heart Failure/diagnostic imaging ; Heart Failure/therapy ; Heart Failure/physiopathology
    Language English
    Publishing date 2023-12-19
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 2638345-7
    ISSN 2047-2412 ; 2047-2404
    ISSN (online) 2047-2412
    ISSN 2047-2404
    DOI 10.1093/ehjci/jead329
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Limitations in Contemporary Pharmacological Stroke Prevention Therapies in Atrial Fibrillation: A Descriptive Literature Review.

    Garot, Philippe / Bergmann, Martin W

    Journal of clinical medicine

    2023  Volume 12, Issue 20

    Abstract: The most common arrhythmia, atrial fibrillation (AF), increases with age and is associated with a 5-fold increased risk of stroke. Although lifelong oral anticoagulation (OAC) is strongly recommended for stroke prevention in patients with AF and ... ...

    Abstract The most common arrhythmia, atrial fibrillation (AF), increases with age and is associated with a 5-fold increased risk of stroke. Although lifelong oral anticoagulation (OAC) is strongly recommended for stroke prevention in patients with AF and CHA
    Language English
    Publishing date 2023-10-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12206594
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Improving Left Atrial Appendage Closure: Reducing the Risk of Device-Related Thrombus.

    Bergmann, Martin W / Meincke, Felix

    JACC. Cardiovascular interventions

    2023  Volume 16, Issue 17, Page(s) 2150–2152

    MeSH term(s) Humans ; Atrial Appendage/diagnostic imaging ; Treatment Outcome ; Thrombosis/diagnostic imaging ; Thrombosis/etiology ; Thrombosis/prevention & control ; Stroke/etiology ; Stroke/prevention & control ; Cardiac Surgical Procedures ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/therapy ; Echocardiography, Transesophageal ; Cardiac Catheterization/adverse effects
    Language English
    Publishing date 2023-08-09
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2452157-7
    ISSN 1876-7605 ; 1936-8798
    ISSN (online) 1876-7605
    ISSN 1936-8798
    DOI 10.1016/j.jcin.2023.06.030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: European registry data on LAA closure: advancing the field of interventional stroke prevention.

    Bergmann, Martin W

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

    2018  Volume 14, Issue 2, Page(s) 135–138

    MeSH term(s) Atrial Appendage ; Atrial Fibrillation ; Humans ; Prospective Studies ; Registries ; Stroke
    Language English
    Publishing date 2018-06-12
    Publishing country France
    Document type Editorial ; Comment
    ZDB-ID 2457174-X
    ISSN 1969-6213 ; 1774-024X
    ISSN (online) 1969-6213
    ISSN 1774-024X
    DOI 10.4244/EIJV14I2A20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The atrial flow regulator: current overview on technique and first experience.

    Paitazoglou, Christina / Bergmann, Martin W

    Therapeutic advances in cardiovascular disease

    2020  Volume 14, Page(s) 1753944720919577

    MeSH term(s) Atrial Function, Left ; Atrial Pressure ; Cardiac Catheterization/instrumentation ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Heart Failure/therapy ; Heart-Assist Devices ; Humans ; Recovery of Function ; Treatment Outcome
    Language English
    Publishing date 2020-09-24
    Publishing country England
    Document type Editorial ; Review
    ZDB-ID 2485062-7
    ISSN 1753-9455 ; 1753-9447
    ISSN (online) 1753-9455
    ISSN 1753-9447
    DOI 10.1177/1753944720919577
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Treatment With an Interatrial Shunt in Heart Failure: 1-Year Outcomes of the PRELIEVE Study.

    Paitazoglou, Christina / Bergmann, Martin W / Kilicaslan, Baris / Kilic, Teoman / Bartunek, Jozef / Pfister, Roman / Iliadis, Christos / Kaya, Ergun Baris / Ozdemir, Ramazan

    JACC. Heart failure

    2024  Volume 12, Issue 3, Page(s) 591–594

    MeSH term(s) Humans ; Heart Failure/surgery ; Atrial Pressure ; Heart Atria ; Cardiac Catheterization ; Stroke Volume
    Language English
    Publishing date 2024-01-03
    Publishing country United States
    Document type Letter
    ZDB-ID 2705621-1
    ISSN 2213-1787 ; 2213-1779
    ISSN (online) 2213-1787
    ISSN 2213-1779
    DOI 10.1016/j.jchf.2023.10.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.

    Bergmann, Martin W

    Trends in cardiovascular medicine

    2017  Volume 27, Issue 6, Page(s) 435–446

    Abstract: NOAC therapy has become the standard for stroke prevention in patients with atrial fibrillation. Yet some patients suffer extracranial bleeding events or have other reasons to seek non-pharmacologic stroke protection. LAA occlusion with the WATCHMAN ... ...

    Abstract NOAC therapy has become the standard for stroke prevention in patients with atrial fibrillation. Yet some patients suffer extracranial bleeding events or have other reasons to seek non-pharmacologic stroke protection. LAA occlusion with the WATCHMAN device has been proven safe and effective for such patients and is now recommended in current guidelines for this patient group; other devices also seek approval.
    MeSH term(s) Atrial Appendage/diagnostic imaging ; Atrial Appendage/physiopathology ; Atrial Fibrillation/complications ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/physiopathology ; Atrial Fibrillation/therapy ; Cardiac Catheterization/adverse effects ; Cardiac Catheterization/instrumentation ; Humans ; Prosthesis Design ; Randomized Controlled Trials as Topic ; Registries ; Risk Assessment ; Risk Factors ; Septal Occluder Device ; Stroke/etiology ; Stroke/prevention & control ; Treatment Outcome
    Language English
    Publishing date 2017-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1097434-9
    ISSN 1873-2615 ; 1050-1738
    ISSN (online) 1873-2615
    ISSN 1050-1738
    DOI 10.1016/j.tcm.2017.03.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: „Flächendeckendes Telemonitoring bei Herzinsuffizienz möglich“

    Prof. Dr. Martin W. Bergmann / Peter Stegmaier

    Monitor Versorgungsforschung, Vol 2022, Iss 03, Pp 28-

    2022  Volume 30

    Abstract: ... darüber hat „Monitor Versorgungsforschung“ mit Prof. Dr. Martin W. Bergmann vom Cardiologicum Hamburg ...

    Abstract Der G-BA hat am 15. Dezember 2020 entschieden, dass Patient:innen mit Herzinsuffizienz auch in der Regelversorgung telemedizinisch betreut werden können. Dementsprechend hat der Erweiterte Bewertungsausschuss den EBM geändert und entsprechende Gebührenordnungspositionen beschlossen. Damit kann Telemonitoring für Patienten mit Herzinsuffizienz von niedergelassenen Ärzten verordnet werden. Telemedizinzentren können von niedergelassenen Kardiologen mit einer KV-Zulassung für die Schrittmacherabfrage betrieben und mit der KV abgerechnet werden. Die KBV hat mit dem GKV-Spitzenverband als Anlage 3 des Bundesmantelvertrags Ärzte (BMV-Ä) eine Vereinbarung von Qualitätssicherungsmaßnahmen nach § 135 Abs. 2 SGB V zum Telemonitoring bei Herzinsuffizienz („QS-V TmHi“) beschlossen. Was das für die Anwendung des Telemonitorings in der Fläche bedeutet, darüber hat „Monitor Versorgungsforschung“ mit Prof. Dr. Martin W. Bergmann vom Cardiologicum Hamburg, einer Unternehmenstochter der Sanecum Gruppe, gesprochen.
    Keywords telemonitoring ; digitalisierung ; herzinsuffizienz ; telemedizin ; qualitätssicherung ; Public aspects of medicine ; RA1-1270 ; Medicine (General) ; R5-920
    Language German
    Publishing date 2022-06-01T00:00:00Z
    Publisher eRelation AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Orale Antikoagulation und Plättchenhemmung nach Vorhofohrverschluss.

    Bergmann, Martin W / Israel, Carsten W

    Herzschrittmachertherapie & Elektrophysiologie

    2017  Volume 28, Issue 4, Page(s) 388–394

    Abstract: In Europe left atrial appendage occluders (LAAO) are most frequently used in patients with contraindications for oral anticoagulation (OAC); therefore, the classical therapeutic OAC scheme from the PROTECT-AF trial (vitamin K antagonist plus ... ...

    Title translation Oral anticoagulation and platelet inhibition after atrial appendage occlusion.
    Abstract In Europe left atrial appendage occluders (LAAO) are most frequently used in patients with contraindications for oral anticoagulation (OAC); therefore, the classical therapeutic OAC scheme from the PROTECT-AF trial (vitamin K antagonist plus acetylsalicylic acid) is usually changed to dual anti-platelet therapy (DAPT) after implantation of a Watchman® or Amulet® LAAO (St. Jude Medical/Abbott, Eschborn, Germany). For many years, patients with an LAAO received DAPT for 1-6 months. The current standard comprises DAPT for 3 months, followed by permanent acetylsalicylic acid monotherapy if the transesophageal echocardiogram excludes a thrombus at the site of the LAAO. In patients with high risk of bleeding, anti-platelet therapy can be stopped at 3 months after an individual risk-benefit calculation. There are no randomized studies on the risk of bleeding and stroke/embolism in patients with an LAA occluder under DAPT versus OAC. Experience from the EWOLUTION registry shows that NOACs may be used as an alternative with low bleeding and thrombus risks. In patients with a suboptimal implantation result, thrombus on the LAAO or specific risk factors, variations of the standard scheme have to be applied and if necessary lifelong DAPT or NOAC therapy has to be used. Thrombi on the LAAO occur in approximately 4-6% of patients and are associated with a very low short-term stroke risk.
    MeSH term(s) Administration, Oral ; Anticoagulants ; Atrial Appendage ; Atrial Fibrillation ; Europe ; Germany ; Humans ; Stroke ; Treatment Outcome
    Chemical Substances Anticoagulants
    Language German
    Publishing date 2017-11-27
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1082953-2
    ISSN 1435-1544 ; 0938-7412
    ISSN (online) 1435-1544
    ISSN 0938-7412
    DOI 10.1007/s00399-017-0537-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study.

    Dickow, Jannis / Gunawardene, Melanie A / Willems, Stephan / Feldhege, Johannes / Wohlmuth, Peter / Bachmann, Martin / Bergmann, Martin W / Gesierich, Wolfgang / Nowak, Lorenz / Pape, Ulrich-Frank / Schreiber, Ruediger / Wirtz, Sebastian / Twerenbold, Raphael / Sheikhzadeh, Sara / Gessler, Nele

    PloS one

    2023  Volume 18, Issue 9, Page(s) e0292017

    Abstract: Background: With the emergence of new subvariants, the disease severity of Severe Acute Respiratory Syndrome Coronavirus-2 has attenuated. This study aimed to compare the disease severity in patients hospitalized with omicron variant infection to those ... ...

    Abstract Background: With the emergence of new subvariants, the disease severity of Severe Acute Respiratory Syndrome Coronavirus-2 has attenuated. This study aimed to compare the disease severity in patients hospitalized with omicron variant infection to those with influenza infection.
    Methods: We compared data from the multicenter observational, prospective, epidemiological "CORONA Germany" (Clinical Outcome and Risk in hospitalized COVID-19 patients) study on patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 to retrospective data on influenza infection cases from November 2016 to August 2022. Severe Acute Respiratory Syndrome Coronavirus-2 cases were classified as wild-type/delta variant before January 2022, or omicron variant from January 2022 onward. The primary outcome was in-hospital mortality, adjusted for age, gender, and comorbidities.
    Results: The study included 35,806 patients from 53 hospitals in Germany, including 4,916 patients (13.7%) with influenza infection, 16,654 patients (46.5%) with wild-type/delta variant infection, and 14,236 patients (39.8%) with omicron variant infection. In-hospital mortality was highest in patients with wild-type/delta variant infection (16.8%), followed by patients with omicron variant infection (8.4%) and patients with influenza infection (4.7%). In the adjusted analysis, higher age was the strongest predictor for in-hospital mortality (age 80 years vs. age 50 years: OR 4.25, 95% CI 3.10-5.83). Both, patients with wild-type/delta variant infection (OR 3.54, 95% CI 3.02-4.15) and patients with omicron variant infection (OR 1.56, 95% CI 1.32-1.84) had a higher risk for in-hospital mortality than patients with influenza infection.
    Conclusion: After adjusting for age, gender and comorbidities, patients with wild-type/delta variant infection had the highest risk for in-hospital mortality compared to patients with influenza infection. Even for patients with omicron variant infection, the adjusted risk for in-hospital mortality was higher than for patients with influenza infection. The adjusted risk for in-hospital mortality showed a strong age dependency across all virus types and variants.
    Trial registration number: NCT04659187.
    Language English
    Publishing date 2023-09-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0292017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top